Live Breaking News & Updates on Wendy Blosser

Stay updated with breaking news from Wendy blosser. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

AccuStem Announce Strategic Clinical and Operational Partnership

31.05.2023 - LONDON and PHOENIX, May 31, 2023 (GLOBE NEWSWIRE) - AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with cancer, today announced a strategic plan to further develop and . ....

Wendy Blosser , Oncocyte Corporation , Chief Executive Officer ,

AccuStem Sciences, Inc.: AccuStem Announce Strategic Clinical and Operational Partnership

LONDON and PHOENIX, May 31, 2023 (GLOBE NEWSWIRE) AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with cancer, today announced ....

City Of , United Kingdom , United States , Wendy Blosser , Accustem Sciences Inc , Oncocyte Corporation , Stem Sciences , Chief Executive Officer ,

AccuStem Sciences, Inc.: AccuStem Sciences Announces Extension of its US Patent Application for SPARE Test for Patients with Breast Cancer

LONDON and PHOENIX, May 02, 2023 (GLOBE NEWSWIRE) AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with cancer, announced today ....

United States , City Of , United Kingdom , Wendy Blosser , Jeff Fensterer , Risk Factor In Accustem Sciences Inc , Trademark Office , Exchange Commission , Accustem Sciences Inc , Stem Sciences , Chief Executive Officer , Risk Factor , Accustem Sciences , Annual Report , Chief Operations , Chief Executive ,

AccuStem Sciences, Inc. Announces Chairman Purchase of Shares

LONDON and PHOENIX, Nov. 22, 2022 (GLOBE NEWSWIRE) AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with cancer, announced that ....

United States , City Of , United Kingdom , Wendy Blosser , Gabriele Cerrone , Jeff Fensterer , Accustem Sciences Inc , Stem Sciences ,

AccuStem Sciences, Inc.: AccuStem Sciences Announces Appointment of Sean McDonald to Board of Directors

LONDON and PHOENIX, Nov. 16, 2022 (GLOBE NEWSWIRE) AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with cancer, announced today ....

United States , City Of , United Kingdom , Wendy Blosser , Jeff Fensterer , Sean Mcdonald , Mckesson Corporation , Accustem Sciences Inc , Stem Sciences , Chief Executive Officer , Adams Capital Management , Precision Therapeutics , Automated Healthcare , Chief Operations , Chief Executive ,